SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of Weighted-Average Assumptions Used To Estimate the Fair Value of Options Granted

The following table presents the weighted-average assumptions used to estimate the fair value of options granted in 2020, 2019 and 2018:

	2020		2019		2018
Expected annual dividend yield	2.0	%	1.9	%	1.4	%
Risk-free interest rate	1.38	%	2.65	%	2.94	%
Expected volatility	51.1	%	50.4	%	48.0	%
Expected life in years	5.2		5.0		5.2

Schedule of Outstanding and Exercisable Options

The following table summarizes information concerning outstanding and exercisable options:

	Weighted Average
	2020				2019				2018
	Shares		Weighted Avg. Exercise Price		Shares		Weighted Avg. Exercise Price		Shares		Weighted Avg. Exercise Price
Outstanding at beginning of year	764,784		$	17.31	596,148		$	11.64	1,001,300		$	11.58
Granted	111,872		$	23.60	1,038,536		$	15.76	17,550		$	31.66
Exercised	(191,780)		$	11.68	(224,750)		$	8.92	(400,203)		$	12.18
Canceled or expired	(23,852)		$	23.71	(645,150)		$	12.50	(22,499)		$	15.24
Outstanding at end of year	661,024		$	19.78	764,784		$	17.31	596,148		$	11.64
Options exercisable at year end	302,283				227,598				341,515
Weighted average fair value per option granted during the year	$	9.12			$	9.16			$	12.87

Schedule of Options Vested and Exercisable or Nonvested, Expected to Vest (Nonvested Outstanding Less Expected Forfeitures)

The following table summarizes information about options vested and exercisable or non-vested that are expected to vest (non-vested outstanding less expected forfeitures) at December 31, 2020:

Range of Exercise Prices					Options outstanding and Exercisable	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value (in millions)
$	5.00	to	$	10.00	123,000	$	6.29	5.53	$	3.6
$	10.01	to	$	15.00	0	$	0.00	0	0.0
$	15.01	to	$	20.00	57,304	$	17.03	2.43	1.1
$	20.01	to	$	25.00	480,720	$	23.55	8.30	5.9
$	5.00	to	$	25.00	661,024	$	19.78	7.27	$	10.6

Schedule of Unvested Stock Options

The following table reflects the activity for all unvested stock options during 2020:

	Shares	Weighted Average Grant- Date Fair Value
Unvested at January 1, 2020	537,186	$	9.38
Granted	111,872	$	9.12
Vested	(269,553)	$	9.19
Forfeited	(20,764)	$	9.61
Unvested at December 31, 2020	358,741	$	9.63

Restricted Stock Award Activity

The following table reflects the activity for restricted stock awards, excluding the restricted stock issued to Directors (in millions, except shares data):

Year Granted	Shares Granted	Outstanding at December 31, 2020	Rights to Cash Dividend	Other Participation Rights	Performance Award	Compensation Expense
						Year Ended December 31,
						2020		2019		2018
2010	175,000	—	Yes	None	No	$	0.0	$	0.0	$	0.1
2011	100,000	—	Yes	None	No	0.0		0.0		0.2
2012	50,000	10,000	Yes	None	No	0 (1)		0 (1)		0 (1)
2016	100,000	—	Yes	None	No	0.0		0 (1)		0.1
2017	53,288	—	Yes	None	No	0.0		0.0		0 (1)
2017	49,600	—	Yes	None	Yes	0.0		0.0		1.5 (2)
2018	5,117	—	Yes	None	No	0.0		0.0		0 (1)
2019	30,251	24,200	Yes	None	No	0.2		0.3		0.0
2019	149,412	57,242	Yes	None	Yes	1.2		1.3		0.0
2020	28,272	28,272	Yes	None	No	0.4		0.0		0.0
2020	43,330	26,446	Yes	None	Yes	0.6		0.0		0.0
					Total	$	2.4	$	1.6	$	1.9

1	less than $0.1 million of expense recorded
2	As a result of the sale of the France business in August 2018 and terms of the performance award, compensation expense of $1.5 million was recorded in discontinued operations for the year ended 2018.

Nonvested Restricted Stock Shares Activity

The following table reflects the activity for all unvested restricted stock during 2020:

	Shares	Weighted Average Grant- Date Fair Value
Unvested at January 1, 2020	172,595	$	23.14
Granted	81,846	$	23.49
Vested	(81,547)	$	23.58
Forfeited	(9,134)	$	23.71
Unvested at December 31, 2020	163,760	$	23.06